These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18761646)

  • 1. Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.
    Burgert TS; Duran EJ; Goldberg-Gell R; Dziura J; Yeckel CW; Katz S; Tamborlane WV; Caprio S
    Pediatr Diabetes; 2008 Dec; 9(6):567-76. PubMed ID: 18761646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin in the treatment of obesity in subjects with normal glucose tolerance.
    Tankova T; Dakovska L; Kirilov G; Koev D
    Rom J Intern Med; 2003; 41(3):269-75. PubMed ID: 15526510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
    Herrmann BL; Saller B; Stratmann M; Berg C; Mann K; Janssen OE
    Horm Metab Res; 2005 Jan; 37(1):49-52. PubMed ID: 15702440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy.
    Valerio G; Licenziati MR; Iannuzzi A; Franzese A; Siani P; Riccardi G; Rubba P
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):279-84. PubMed ID: 16679220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects.
    James AP; Watts GF; Mamo JC
    Diabetes Obes Metab; 2005 Jul; 7(4):381-9. PubMed ID: 15955124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
    Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being.
    Moon RJ; Bascombe LA; Holt RI
    Diabetes Obes Metab; 2007 Jan; 9(1):143-5. PubMed ID: 17199734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects.
    Tamura Y; Watada H; Sato F; Kumashiro N; Sakurai Y; Hirose T; Tanaka Y; Kawamori R
    Diabetes Obes Metab; 2008 Sep; 10(9):733-8. PubMed ID: 17941868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.
    Casteels K; Fieuws S; van Helvoirt M; Verpoorten C; Goemans N; Coudyzer W; Loeckx D; de Zegher F
    Pediatr Diabetes; 2010 Feb; 11(1):61-9. PubMed ID: 19496972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of abnormal glucose homeostasis and insulin resistance in Turkish obese children and adolescents.
    Atabek ME; Pirgon O; Kurtoglu S
    Diabetes Obes Metab; 2007 May; 9(3):304-10. PubMed ID: 17391156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance.
    de Aguiar LG; Bahia LR; Villela N; Laflor C; Sicuro F; Wiernsperger N; Bottino D; Bouskela E
    Diabetes Care; 2006 May; 29(5):1083-9. PubMed ID: 16644641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metformin vs. placebo treatment on serum fatty acids in non-diabetic obese insulin resistant individuals.
    Rodríguez Y; Giri M; Feyen E; Christophe AB
    Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):391-7. PubMed ID: 15519498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS; Kazemi F; Najafian A; Mohammady M; Aminorroaya A; Amini M
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.